First-hand experience sparks Rhinomed to develop high comfort swab
Posted 10 December 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. In April this year, as the world came to grips with the global COVID-19 pandemic, Rhinomed CEO Michael…
Monash University partners with HuiKang Bio-Tech to develop new class of anti-infectives
7 December 2020 Monash University has announced a collaboration with leading protein and peptide experts, HuiKang Bio-Tech, to develop a new class of anti-infectives. The collaboration is being led by Professor Ray Norton from the Monash Institute of…
Stephens Lawyers & Consultants: ACCC Enforcement Proceedings – Unfair Contract Terms
1 December 2020 From Katarina Klaric (Principal & Director) and Peter Divitcos (Lawyer), Stephens Lawyers & Consultants Standard form contracts are being subjected to increased scrutiny for unfair contract terms by regulators. On-line terms and conditions are of…
mexec uses COVID grant to assist industry job seekers
Posted 26 November 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. With companies across the industry forced to let staff go, Marilyn Jones knew that 2020 was…
Kynetyka’s DVTect™ technology granted Australian patent.
Posted 25 November 2020 Melbourne Australia: Kynetyka Technologies Pty Ltd (“Kynetyka”), a privately held Melbourne-based medical device company is pleased to announce that the Australian patent for its DVTect™ technology has been granted. The patent “A screening test…
Even from a distance, Commercial Eyes is thriving
Posted 12 November 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. This story was submitted by Andrew Carter, Managing Director Do you remember saying – “I catch…
Cancer Therapeutics CRC Drug Discovery Enters Phase 1 Clinical Trials
Posted 12 November 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. In a rare achievement for the Australian biotechnology industry, a new potential cancer therapy developed in…
Dr Keith McLean and Theodora Elia-Adams Join BioMelbourne Network Board
12 November 2020 BioMelbourne Network is pleased to announce the appointment of Theodora Elia-Adams and Dr Keith McLean to the BioMelbourne Network Board. Keith McLean was elected as a Board Director at the 2020 Annual General Meeting on…
Kynetyka supported by Victoria’s Medical Device Partnering Program to develop DVTect™ technology
Posted 11 November 2020 Kynetyka Technologies Pty Ltd (“Kynetyka”), a privately held Melbourne-based medical device company led by Craig Newton and Xenia Sango, is delighted to announce that it has secured the support of Victoria’s Medical Device Partnering…
Dr Cathy Foley To Be Australia’s Next Chief Scientist
9 November 2020 BioMelbourne Network congratulates Dr Cathy Foley on her appointment as Chief Scientist of Australia. Dr Foley has spent the last two years as Chief Scientist at CSIRO, where she has worked for nearly 36 years, beginning as a…
Annual Report 2020 Cover
The images featured on our covers and many other images throughout the 2020 Annual Report are provided by BioMelbourne Network member organisations. We extend thanks to those who submitted images, and to all of our members for their…
Livac cuts through pandemic to enter US market
Posted 29 October 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. What do you do when you’re preparing to launch your surgical device into the US market…
